Perrigo Company plc

PRGO • Drug Manufacturers - Specialty & Generic

$16.17

— 0.00 (0.00%)

Current price

EarningsLatest report: Mar 28, 2026

BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.

Market Cap

$2.23B

Growth

5.1%

Cash Flow

5/5

Trend

Stable

Evidence

Positive free cash flow · 1.05Consistent free cash flow · 5/5Healthy liquidity · 2.76Weak profitability

Financial data as of: Mar 28, 2026, 12:00 AM UTCLast earnings update: May 6, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$16.17

Change0.00%

Shares Out138.70M

Market Cap$2.23B

Enterprise Value$5.52B

52W Range9.23 - 28.44

Beta0.52

P/E-1.23

P/S0.53

P/B0.89

P/FCF20.72

EV/Sales1.32

Price$16.17

Change0.00%

Shares Out138.70M

Market Cap$2.23B

Enterprise Value$5.52B

52W Range9.23 - 28.44

Beta0.52

P/E-1.23

P/S0.53

P/B0.89

P/FCF20.72

EV/Sales1.32

EV/EBITDA-6.59

EV/FCF51.27

Earnings Yield-81.45%

FCF Yield4.83%

Dividend Yield7.12%

Gross Margin35.14%

Oper. Margin8.07%

Profit Margin-33.51%

Debt/Eq1.35

Current Ratio2.76

Quick Ratio1.63

Revenue 5Y5.14%

Target$36.20

Target Upside123.87%

Target Median$36.00

Target Range20.00 - 54.00

Volume2.74M

Avg Volume2.93M

EPS Surprise0.04

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

27/100

Financial Strength

Debt, cash, stability

65/100

Growth Potential

Revenue and expansion

58/100

Price Attractiveness

Cheap or expensive today

92/100

Why this score▼

Positive free cash flow · 1.05Consistent free cash flow · 5/5Healthy liquidity · 2.76Weak profitability

Analyst view

Analyst sentiment and price target

PRGO

Analyst sentiment

Based on 36 analyst votes · 2026-10-20

68/100

Neutral

Bullish

Hold

Bearish

Price Target

2026-06-25

Low

$20.00

Mean

$36.20

Median

$36.00

High

$54.00

Company Overview

IPO: 12/17/1991

Industry: Drug Manufacturers - Specialty & Generic

P/B i: 0.89

Debt / Equity i: 1.35

Operating Margin: 8.07%

Net Margin: -33.51%

ROE i: -

ROIC: -

Financial Health

Score13 / 20

Debt / Equity: 1.35

Current Ratio: 2.76

Quick Ratio: 1.63

Status: Good

Insider Transactions

Recent executive and insider activity

Alford Bradley A

Transaction: 06/12/2026

SELL

Change

-976

Price

Not reported

Filing

06/16/2026

Type

SELL

Alford Bradley A

Transaction: 06/12/2026

SELL

Change

-469

Price

$10.99

Filing

06/16/2026

Type

SELL

Manzone Albert

Transaction: 06/12/2026

BUY

Change

+1,069

Price

Not reported

Filing

06/16/2026

Type

BUY

Insider	Type	Change	Price	Transaction	Filing
Alford Bradley A	SELL	-976	Not reported	06/12/2026	06/16/2026
Alford Bradley A	SELL	-469	$10.99	06/12/2026	06/16/2026
Manzone Albert	BUY	+1,069	Not reported	06/12/2026	06/16/2026
Parker Geoffrey M.	SELL	-976	Not reported	06/12/2026	06/16/2026
Parker Geoffrey M.	SELL	-469	$10.99	06/12/2026	06/16/2026
Lockwood-Taylor Patrick	SELL	-25,230	Not reported	06/05/2026	06/09/2026
Lockwood-Taylor Patrick	SELL	-12,906	$10.83	06/05/2026	06/09/2026
Atkinson Charles	SELL	-1,835	$10.83	06/05/2026	06/08/2026
Atkinson Charles	SELL	-6,690	Not reported	06/05/2026	06/08/2026
Ball David	SELL	-2,867	Not reported	06/05/2026	06/08/2026
Ball David	SELL	-1,037	$10.83	06/05/2026	06/08/2026
Bezerra Eduardo Guarita	SELL	-9,175	Not reported	06/05/2026	06/08/2026
Bezerra Eduardo Guarita	SELL	-2,235	$10.83	06/05/2026	06/08/2026
Lennox Abigail	SELL	-1,996	$10.83	06/05/2026	06/08/2026
Lennox Abigail	SELL	-3,823	Not reported	06/05/2026	06/08/2026
Willis Robert	SELL	-3,441	Not reported	06/05/2026	06/08/2026
Willis Robert	SELL	-1,797	$10.83	06/05/2026	06/08/2026
Khoury Roberto	SELL	-7,888	Not reported	06/05/2026	06/08/2026
Khoury Roberto	SELL	-4,118	$10.83	06/05/2026	06/08/2026
Alford Bradley A	SELL	-3,507	$10.84	05/15/2026	05/15/2026

About the Company

Perrigo Company plc

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Source - link

Peers

ATEC BHC FOLD HCM HTFL LIVN SGRY SRRK SUPN TARS

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

Perrigo Co PLC (PRGO) Stock Up 3.9% and Still Undervalued -- GF Score: 60/100

On October 09, 2026, Perrigo Co PLC (PRGO) shares rose by 3.9%, bringing the current price to $15.06. This movement is notable within the context of its 52-week

GuruFocus

Perrigo (PRGO) Moves 6.1% Higher: Will This Strength Last?

Perrigo (PRGO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Investment Research

Squarepoint Ops LLC Cuts Position in Perrigo Company plc $PRGO

Squarepoint Ops LLC reduced its stake in shares of Perrigo Company plc (NYSE: PRGO) by 95.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,900 shares of the company's stock after selling 443,842 shares during the quarter.

Defense World

Perrigo (PRGO) Up 13.8% Since Last Earnings Report: Can It Continue?

Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research

Perrigo to Attend the Barclays Global Consumer Conference

DUBLIN, Aug. 27, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that Interim President and CEO Albert Manzone and CFO Eduardo Bezerra are scheduled to participate in investor meetings at the Barclays Global Consumer Conference on Thursday, September 10th, 2026. About Perrigo Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe.

PRNewsWire

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-05-06	0.39	0.43	0.04
2026-02-26	0.8	0.77	-0.03
2025-11-05	0.75	0.8	0.05
2025-08-06	0.59	0.57	-0.02
2025-05-07	0.56	0.6	0.04
2025-02-27	0.92	0.93	0.01
2024-11-06	0.82	0.81	-0.01
2024-08-02	0.48	0.53	0.05
2024-05-07	0.24	0.29	0.05
2024-02-27	0.83	0.86	0.03
2023-11-07	0.65	0.64	-0.01
2023-08-08	0.54	0.63	0.09